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Significance of Clinical-Pathologic Correlation in a Case of
Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) Syndrome
Mehrnoosh Tashakori MD PhD1, Beena Ahsan MD1, Daniel Hertel MD2, Richard H Huggins MD2, Sean R Williamson MD1, Adrian H Ormsby MD1
1Department of Pathology and Laboratory Medicine, 2Department of Dermatology,
Henry Ford Health System, Detroit, Michigan

BACKGROUND

DISCUSSION

Hereditary leiomyomatosis and renal cell carcinoma
syndrome (HLRCC) is a rare genetic disease, characterized
by cutaneous leiomyomata, uterine leiomyomata and renal
tumor. This syndrome is inherited in an autosomal dominant
manner and caused by mutations in the fumarate hydratase
(FH) gene (1). This genetic alteration predisposes these
patients to more aggressive renal tumor compared to other
hereditary renal tumors. Hence, it is of great importance to
suspect this syndrome upon identification of multiple
cutaneous leiomyomata. Here, we present a case report of
such rare syndrome, underscoring the significance of
clinical-pathologic correlation in identifying patients at high
risk of aggressive renal tumor.

HLRCC, also known as Reed’s syndrome, is a rare familial
syndrome characterized by multiple, often symptomatic,
cutaneous and uterine leiomyomata as well as kidney
tumors. It is caused by germline mutations in FH gene, which
encodes a critical component of citric acid (Krebs) cycle.
Lack of FH protein results in a metabolic shift from oxidative
phosphorylation to aerobic glycolysis and, consequently,
upregulation of genes that promote renal oncogenesis (2).
Such alterations also result in the accumulation of 2succinocysteine (2SC) protein which can be detected by
immunohistochemistry and has high sensitivity and
specificity fpr FH-deficient tumors. However, FH staining
does not show a robust association with FH gene mutation,
as evidence by FH immunopositivity in our case (3). The
characteristic morphologic feature in HLRCC-associated
RCC and uterine leiomyomas is large eosinophilic nucleoli
surrounded by perinucleolar halos. However, no helpful
morphologic clue has been suggested for cutaneous
leiomyomas with FH gene mutations, emphasizing that the
presence of multiple cutaneous leiomyomas should raise the
possibility of HLRCC and, hence, prompt the screening for
identifying such patients. Given that renal tumors with FH
mutations are more aggressive compared to other hereditary
renal tumors, it is of great importance to suspect this
syndrome upon identification of multiple cutaneous
leiomyomata.

A

CLINICAL PRESENTATION
• A 54 years old Bengali male presented with multiple
painful large firm skin-colored to brown skin lesions over
left lower chest/ upper abdomen and back in a T6
dermatomal distribution (Figure A-C).
• He has had such lesions for 26 years, with increase in
size and number as well as worsening of pain over time.
• Patient did seek medical help due to progressive severe
pain.
• A 4-mm punch biopsy of skin lesion on left chest was
performed and the histopathological examination revealed
a proliferation of smooth muscle in the reticular dermis,
consistent with leiomyoma (FigureD-E).
• The positive immunohistochemical staining for smooth
muscle antigen (SMA) supported the diagnosis (Figure F).
• The FH expression detected on immunohistochemical
studies, which was neither supportive nor against the
diagnosis of HLRCC (Figure G).
• Since this patient has the major criterion for HLRCC,
histopathologically
confirmed
multiple
cutaneous
leiomyomata, he most likely has this syndrome.
• Mutation analysis, genetic counseling and, more
importantly, the evaluation of kidneys for possible
malignancy are hindered due to the lack of insurance
coverage for genetic testing.
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